Bescan SPRL
Bescan reported total assets of 528,845 € at the end of the 2025 financial year (annual accounts filed with the NBB on 20 Jul 2026).
The score of Bescan shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +163 % Total assets +100 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Bescan's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 83,537 € | ||||
| Equity | 204,997 € | ||||
| Cash | 42,091 € | ||||
| EBITDA | 117,703 € | ||||
| Total assets | 528,845 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 20 Jul 2026
- Year ended 31 Dec 2024filed on 01 Jul 2025
- Year ended 31 Dec 2023filed on 26 Sep 2024
- Year ended 31 Dec 2022filed on 24 Aug 2023
- Year ended 31 Dec 2021filed on 29 Jul 2022
Bescan's financial analysis
- Solvency38.8%sector median: 43.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Bescan
Bescan's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0650.630.567
- VAT number
- BE0650630567
- Peppol
- Registered · 0208:0650630567 · as of 10 Nov 2026
- Legal form
- SPRL
- Incorporated
- 21 Mar 2016
- Registered office
- 1435 Mont-Saint-Guibert
- Latest accounts
- 2025 · filed on 20 Jul 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Bescan (SPRL) has been based in Mont-Saint-Guibert since 2016, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 83,537 € and equity of 204,997 €; its revenue is not published. Its solvency stands at 38.8%, below the median of its sector (43.9%).
Companies similar to Bescan
Companies in the same business, of comparable size and area, outside its group.
- Phenox Wholesale of pharmaceutical and medical goods Overijse · balance sheet 887,046 €
- APIX Activities of agents involved in the wholesale of furniture, household goods, hardware and ironmongery Mont-Saint-Guibert · balance sheet 121,707 €
- InnoRehab Wholesale of pharmaceutical and medical goods Ottignies-Louvain-la-Neuve · balance sheet 175,496 €
- CAWET Orthopédie Wholesale of pharmaceutical and medical goods Chimay · balance sheet 392,771 €
- W.P. MED Activities of agents involved in the wholesale of other particular products Aywaille · balance sheet 403,029 €
- Barette Wholesale of pharmaceutical and medical goods Ixelles · balance sheet 615,019 €
- DB Medic Wholesale of pharmaceutical and medical goods Bruges · balance sheet 579,690 €
- Paloma Curiosa Wholesale of pharmaceutical and medical goods Roeselare · balance sheet 710,783 €
Frequently asked questions about Bescan
What is the revenue of Bescan?
Bescan files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Bescan?
In Belgium, the VAT number is the company number prefixed with BE: BE0650630567 for Bescan, if the company is VAT-registered. Its company number (CBE) is 0650.630.567.
Where is the registered office of Bescan?
According to the CBE register, the registered office of Bescan is in 1435 Mont-Saint-Guibert.
What is the equity of Bescan?
At the close of the 2025 financial year, the equity of Bescan amounts to 204,997 €, a solvency of 38.8% of total assets.
Who manages Bescan?
The register lists 1 active mandates at Bescan. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Bescan
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →